New stroke treatment could help patients with medium-artery blockages
NCT ID NCT07347665
First seen Jan 17, 2026
Summary
This study looks at whether removing a blood clot from a medium-sized brain artery (M2 segment) helps people recover better after a stroke. About 200 adults who have had a stroke and are not helped by clot-busting medicine will be randomly assigned to get either standard care or standard care plus a procedure to remove the clot. The main goal is to see if more people can live independently 90 days later.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hyogo Medical University
NOT_YET_RECRUITINGNishinomiya, Hyōgo, 663-8501, Japan
-
Hyogo Medical University
RECRUITINGNishinomiya, Hyōgo, 663-8501, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.